Our parents, ourselves: How American health care imperils middle age and beyond

Our Parents, Ourselves: How American Health Care Imperils Middle Age and Beyond

Volumn , Issue , 2005, Pages

  Turiel, Judith Steinberg ^a  

^a Lifelong Medical Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887661731     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (459)

1. Abbott RD, LR White, GW Ross, et al. 2004. Walking and dementia in physically capable elderly men. JAMA 292:1447-53.
2. Abelson R, and M Petersen. 2003. An operation to ease back pain bolsters the bottom line, too. New York Times (12/31/03) A1.
3. AD2000 Collaborative Group. 2004. Long-term doneqezil treatment in 565 patients with Alzheimer's disease. Lancet 363:2105-15.
4. Aiken LH, SP Clarke, RB Cheung, et al. 2003. Educational levels of hospital nurses and surgical patient mortality. JAMA 290:1617-23.
5. Aiken LH, SP Clarke, DM Sloane, et al. 2002. Hospital nurse staffing and patient mortality, nurse burnout, and job dissatisfaction. JAMA 288:1987-93.
6. Aisen PS, KA Schafer, M Grundman, et al. 2003. Effects of rofecoxib or naproxen vs placebo on Alzheimer Disease progression. JAMA 289:2819-26.
7. Albert MS, and DA Drachman. 2000. Alzheimer's Disease: what is it, how many people have it, and why do we need to know? Neurology 55:166-68.
8. ALLHAT Officers. 2002. Major outcomes in high-risk hypertensive patients randomized to angiotensive-converting enzymes inhibitor or calcium channel blocker vs. diuretic. JAMA 288:2981-97.
9. Altman D. 2004. The new Medicare prescription-drug legislation. NEJM 350:9-10.
10. Altman S, and C Parks-Thomas. 2002. Controlling spending for prescription drugs. NEJM 346:855-56.
11. Anand G. 2003. The big secret in health care: rationing is here. Wall Street Journal (9/12/03) A1.
12. Anderson GL, HL Judd, AM Kaunitz, et al. 2003. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures. JAMA 290:1739-48.
13. Angell M. 1999. Care for the dying-Congressional mischief. NEJM 341:923-24.
14. Angell M. 2004. The truth about the drug companies. New York Review of Books (7/15/04) 52-58 (article appears in different form in The truth about the drug companies: how they deceive us and what to do about it [New York: Random House]).
15. Angiers N. 1995. If you're really ancient, you may be better off. New York Times (6/11/95) Science 1.
16. Arendell T, and CL Estes. 1991. Older women in the post-Reagan era. Int J Health Serv 21:59-73.
17. Asch SM, EM Sloss, C Hogan, et al. 2000. Measuring underuse of necessary care among elderly Medicare beneficiaries using inpatient and outpatient claims. JAMA 284:2325-33.
18. Ashton CM, J Souchek, NJ Petersen, et al. 2003. Hospital use and survival among veterans affairs beneficiaries. NEJM 349:1637-46.
19. Avorn J. 2001. Improving drug use in elderly patients. JAMA 286:2866-68.
20. Baker DW, JJ Sudano, JM Albert, et al. 2001. Lack of health insurance and decline in overall health in late middle age. NEJM 345:1106-12.
21. Baker LC. 1999. Association of managed care market share and health expenditures for FFS Medicare patients. JAMA 281:432-47.
22. Balfour JL, and GA Kaplan. 2002. Neighborhood environment and loss of physical function in older adults: evidence from the Alameda County study. Am J Epidem 155:507-15.
23. Ball K, DB Berch, KF Helmers, et al. 2002. Effects of cognitive training interventions with older adults. JAMA 288:2271-81.
24. Bascom P, and SW Tolle. 2002. Responding to requests for physician-assisted suicide. JAMA 288:91-98.
25. Bassuk S, TA Glass, and LF Berkman. 1999. Social disengagement and incident cognitive decline in community-dwelling elderly persons. Ann Intern Med 131:165-73.
26. Becker E, and R Pear. 2004. Trade agreement may undercut importing of inexpensive drugs. New York Times (7/12/04) A1.
27. Belluck P. 2001. Nuns offer clues to Alzheimer's and aging. New York Times (5/7/01) A1.
28. Berenson A, G Harris, B Meier, et al. 2004. Despite warnings, drug giant took long path to Vioxx recall. New York Times (12/14/04)A1.
29. Berkman LF. 2000. Which influences cognitive function: living alone or being alone? Lancet 355:1291-92.
30. Binder EF, M Brown, DR Sinacore, et al. 2004. Effects of extended outpatient rehabilitation after hip fracture. JAMA 292:837-46.
31. Bindman AB, and DA Haggstrom. 2003. Small steps or a giant leap for the uninsured? JAMA 290:816-818.
32. Bischoff-Ferrari HA, B Dawson-Hughes, WC Willett, et al. 2004. Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999-2006.
33. Black AL, and RA Pearlman. 2001. Desire for physician-assisted suicide: requests for a better death? Lancet 358:344-45.
34. Blackburn E. 2004. Bioethics and the political distortion of biomedical science. NEJM 350:1379-80.
35. Blass JP, and RR Ratan. 2003. "Silent" strokes and dementia (editorial). NEJM 348:1277-78.
36. Bloch MG. 2004. Health care disparities-science, politics, and race. NEJM 350:1568-70.
37. Blumenthal D. 2004. Doctors and drug companies. NEJM 351:1885-90.
38. Bodenheimer T. 1999. Long-term care for frail elderly people-the On Lok model. NEJM 341:1324-28.
39. Bodenheimer T. 2001. Affordable prescriptions for the elderly. JAMA 286:1762-63. Boeve B, J McCormick, G Smith, et al. 2003. Mild cognitive impairment in the oldest old. Neurology 60:477-80.
40. Brach J, S Fitzgerald, AB Newman, et al. 2003. Physical activity and functional status in community-dwelling older women. Arch Intern Med 163:2565-71.
41. Brennan TA. 2002. Luxury primary care-market innovation or threat to access? NEJM 346:1165-68.
42. Broder D. 1999. Voters yearn for honest president. San Francisco Examiner (11/7/99) A6.
43. Brody H. 1997. Medical futility: a useful concept? In Zucker MB, and HD Zucker, eds. Medical futility and the evaluation of life-sustaining interventions. Cambridge: Cambridge University Press.
44. Brookmeyer R, and C Kawas. 1998. Projections of Alzheimer's Disease in the United States and public health impact of delaying disease onset. Am J Public Health 88:1337-42.
45. Bruce ML, TR TenHave, CF Reynolds III, et al. 2004. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients. JAMA 291:1081-91.
46. Budetti PP. 2004. 10 years beyond the Health Security Act failure. JAMA 292:2000-06.
47. Budson AE, and BH Price. 2005. Memory dysfunction. NEJM 352:692-99.
48. Burns A, and M Zaudis. 2002. Mild cognitive impairment in older people. Lancet 360:1963-65.
49. Burt RA. 1997. The Supreme Court speaks. NEJM 337:1234-46.
50. Butler RN. 1996. On behalf of older women. NEJM 334:794-96.
51. Callahan D. 1998. False hopes: why America's quest for perfect health is a recipe for failure. New York: Simon & Schuster.
52. Callahan D, RHJ Ter Meulen, and E. Topinkova. 1995. A world growing old: the coming health care challenges. Washington DC: Georgetown University Press.
53. Calman NS. 2004. So tired of life. Health Aff 24:228-32.
54. Canedy D. 2002. Florida redoubles efforts for the elderly. New York Times (5/5/02) A1.
55. Cannon CP, E Braunwald, CH Hill, et al. 2004. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. JAMA 350:1495-1511.
56. Carlson MC, LP Fried, QL Xue, et al. 1999. Association between executive at-tention and physical functional performance in community-dwelling older women. J Gerontol: Soc Sci 54:S262-70.
57. Cassel CK. 2002. Use it or lose it. JAMA 288:2333-35.
58. Cassel CK, RW Besdine, and LC Siegel. 1999. Restructuring Medicare for the next century: what will beneficiaries really need? Health Aff 18:118-131.
59. Casserly I. 2004. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363:1139-46.
60. Cauley JA, J Robbins, Z Chen, et al. 2003. Effects of estrogen plus progestin on risk of fracture and bone mineral density. JAMA 290:1729-38.
61. Chlebowski RT, SL Hendrix, RD Langer, et al. 2003. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 289:3243-53.
62. Chlebowski RT, J Wactawski-Wende, C Ritenbaugh, et al. 2004. Estrogen plus progestin and colorectal cancer in postmenopausal women. NEJM 350:991-1004.
63. Ciechanowski P, E Wagner, K Schmaling, et al. 2004. Community-integrated home-based depression treatment in older adults. JAMA 291:1569-77.
64. City of Berkeley Health and Human Services Department. 1999. Health status report. Berkeley, California.
65. City of Berkeley Health and Human Services Department. 2002. Health status report: mortality and hospitalizations. Berkeley.
66. Cohen L. 1998. No aging in India: Alzheimer's, the bad family, and other modern things. Berkeley and Los Angeles: University of California Press.
67. Cohen LM, MJ Germain, and DM Poppel. 2003. Practical considerations in dialysis withdrawal. JAMA 289:2113-19.
68. Colcombe SJ, AF Kramer, KI Erickson, et al. 2004. Cardiovascular fitness, cortical plasticity, and aging. PNAS 101:3316-21.
69. Cook D, G Rocker, J Marshall, et al. 2003. Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. NEJM 349:1123-32.
70. Cooney LM, GJ Kennedy, KA Hawkins, et al. 2004. Who can stay at home? Arch Intern Med 164:357-60.
71. Correa T. 2001. A doctor says no to his HMO. Fresno Bee (3/38/01) C1.
72. Coyle JT. 2003. Use it or lose it-Do effortful mental activities protect against dementia? NEJM 348:2489-90.
73. Crenshaw A. 2000. Study cites medical bills for many bankruptcies. Washington Post (4/25/00) E1.
74. Crimmins EM, SL Reynolds, and Y Saito. 1999. Trends in health and ability to work among the older working-age population. J Gerontol 54 B:S33-40.
75. Crimmins EM, Y Saito, and SL Reynolds. 1997. Further evidence on recent trends in the prevalence and incidence of disability among older Americans from two sources: The LSOA and NHIS. J Gerontol: Soc Sci 52: S59-S71.
76. Croghan TW, and PM Pittman. 2004. The medicine cabinet: what's in it, why, and can we change the contents? Health Aff 23:23.
77. Crowley WF, L Sherwood, P Salber, et al. 2004. Clinical research in the United States at a crossroads. JAMA 291:1120-26.
78. Cummings JL. 2004. Alzheimer's Disease. NEJM 351:56-67.
79. Cushman J, LH Kuller, R Prentice, et al. 2004. Estrogen plus progestin and risk of venous thrombosis. JAMA 292:1573-80.
80. Daviglus JM, K Liu, A Pirzada, et al. 2003. Favorable cardiovascular risk profile in middle age and health-related quality of life in older age. Arch Intern Med 163:2460-68.
81. Davis M, J Poisal, G Charles, et al. 1999. Prescription drug coverage, utilization, and spending among Medicare beneficiaries. Health Aff 18:231-43.
82. Day L, B Fildes, I Gordon, et al. 2002. Randomised factorial trial of falls prevention among older people living in their own home. BMJ 325:128-31.
83. Dean C. 2003. Grams. JAMA 290:2380.
84. Detsky AS, and CD Naylor. 2003. Canada's health care system-reform delayed. NEJM 349:804-10.
85. Deyo RA, A Nachemson, and S Mirza. 2004. Spinal-fusion surgery-the case for restraint. NEJM 350:722-26.
86. Drazen JM. 2003. Decisions at the end of life. NEJM 349:1109-10.
87. Duenwald M, and B Stamler 2004. On their own, in the same boat. New York Times (4/13/04) Retirement Suppl, 1.
88. Dukes MNG. 2002. Accountability of the pharmaceutical industry. Lancet 360:1682-84.
89. Durrett C, and K McCamant. 1994. Co-housing: a contemporary approach to housing ourselves. Berkeley: Ten Speed Press.
90. Editors. 1993. Do doctors short-change old people? Lancet 342:1-2.
91. Editors. 2002a. Countering delays in introduction of generic drugs. Lancet 359:181.
92. Editors. 2002b. A way forward for U.S. health care? Lancet 360:7.
93. Editors. 2003a. The coming crisis of longterm care. Lancet 361:1755.
94. Editors. 2003b. The statin wars: why AstraZeneca must retreat. Lancet 362:1341.
95. Editors. 2004a. Keeping ideology and bureaucracy out of science. Lancet 363:501.
96. Editors. 2004b. AD 2000: Donepezil in Alzheimer's disease. Lancet 363:2100-2101.
97. Editors. 2004c. Vioxx: an unequal partnership between safety and efficacy. Lancet 364:1287.
98. Egan T. 2003. A prescription plan hailed as a model is budget casualty. New York Times (3/5/03) A1.
99. Elias MF, A Beiser, P Wolf, et al. 2000. The preclinical phase of Alzheimer's Disease. Arch Neurol 57:808-13.
100. Elliott S, and N Ives. 2004. Selling prescription drugs to the consumer. New York Times (10/12/04) C1.
101. Evans JG. 2003. Drugs and falls in later life. Lancet 361:448.
102. Families USA. 2003. Going without health insurance: nearly 1 in 3 non-elderly Americans. www.familiesusa.org, (publication no. 03-103).
103. Families USA. 2004a. Sticker shock: rising prescription drug prices for seniors. www.familiesusa.org, (publication no. 04-103).
104. Families USA. 2004b. One in three: non-elderly Americans without health insurance. www.familiesusa.org, (publication no. 04-104).
105. Federman AD, AS Adams, D Ross-Degnan, et al. 2001. Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease. JAMA 286:1732-39.
106. Fein R. 2003. Universal health insurance-Let the debate resume. JAMA 290:818-20.
107. Ferrucci L, JM Guralnik, ME Salive, et al. 1996. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 44:237-41.
108. Feskanich D, W Willett, and G Colditz. 2002. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA 288:2300-06.
109. Feskens EJ, LLM Havekes, and S Kalmijn. 1994. A polipoprotein e4 allele and cognitive decline in elderly men. BMJ 309:1202-04.
110. Fiore RN. 1999. Caring for ourselves: peer care in autonomous aging. In Walker MV, ed. Mother time: women, aging, and ethics. Lanham MD: Rowman & Littlefield.
111. Fisher ES. 2003. Medical care-Is more always better? NEJM 349:1665-67.
112. Fletcher AE, GM Price, ESW Ng, et al. 2004 Population-based multidimensional assessment of older people in UK geriatric practice: a clusterrandomised factorial trial. Lancet 364:1667-77.
113. Fontanarosa PB, R Drummond, and CD De Angelis. 2004. Postmarketing surveillance-lack of vigilance, lack of trust. JAMA 292:2647-50.
114. Fratiglioni L, H Wang, K Ericsson, et al. 2000. Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 355:1315-19.
115. Freedman VA, LG Martin, and RF Schoeni. 2002. Recent trends in disability and functioning among older adults in the United States. JAMA 288:3137-46.
116. Freudenheim M. 1999. Big HMO to give decisions on care back to doctors. New York Times (11/28/99) A1.
117. Freudenheim M. 2003. Employees paying ever-bigger share for health care. New York Times (9/10/03) A1.
118. Freudenheim M. 2004a. Broader health coverage may depend on less. New York Times (1/20/04) C1.
119. Freudenheim M. 2004b. Companies limit health coverage of many retirees. New York Times (2/3/04) A1.
120. Freudenheim M. 2004c. Using new Medicare billions, HMO's again court elderly. New York Times (3/9/04) A1.
121. Freudenheim M. 2004d. Record level of Americans not insured on health. New York Times (8/27/04) C1.
122. Freudenheim M. 2004e. Cost of insuring workers' health increases 11.2%. New York Times (9/10/04) C1.
123. Fried LP, M Freedman, TE Endres, et al. 1997. Building communities that promote successful aging. West J Med 167:219.
124. Fried LP, SJ Herdman, DE Kuhn, et al. 1991. Preclinical disability. J Aging Health 3:285-99.
125. Fried LS. 2003. Establishing benchmarks for quality care for an aging population: caring for vulnerable older adults. Ann Intern Med 139:784-86.
126. Fried TR, EH Bradley, VR Towle, et al. 2002. Understanding the treatment preferences of seriously ill patients. NEJM 346:1061-66.
127. Friedland R, T Fritsch, KA Smythe, et al. 2001. Patients with Alzheimer's Disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci 98:3440-45.
128. Friedrich MJ. 2002. Biological secrets of exceptional old age. JAMA 288:2247-53.
129. Fries JF. 1980. Aging, natural death, and the compression of morbidity. NEJM 303:130-35.
130. Fries JF. 2002. Reducing disability in older age. JAMA 288:N3164-5.
131. Frontline (PBS). 2003. Dangerous prescription (viewed 11/13/03). www.pbs.org/wgbh/pages/frontline/shows/prescription.
132. Gallow JJ, and BD Leibowitz. 1999. The epidemiology of late life mental disorders in the community. Psychiatr Serv 50:1158-66.
133. Ganzini L, ER Goy, LL Miller, et al. 2003. Nurses' experiences with hospice patients who refuse food and fluids to hasten death. NEJM 349:359-65.
134. Ganzini L, TA Harvath, A Jackson, et al. 2002. Experiences of Oregon nurses and social workers with hospice patients who requested assistance with suicide. NEJM 347:582-88.
135. Ganzini L, HD Nelson, TA Schmidt, et al. 2000. Physicians' experience with the Oregon Death with Dignity Act. NEJM 342:557-63.
136. Gawande A. 2003. Desperate measures. New Yorker (5/5/03) 70-81.
137. Gill MR. 2004. Advance care planning. NEJM 350:7-8.
138. Gill TM, H Allore, and Z Guo. 2003. Restricted activity and functional decline among community-living older persons. Arch Intern Med 163:1317-22.
139. Gill TM, D Baker, M Gottshalk, et al. 2002. A program to prevent functional decline in physically frail elderly persons who live at home. NEJM 347:1068-74.
140. Gillick MR. 1994. Choosing medical care in old age. Cambridge MA: Harvard University Press.
141. Gillick MR. 2000. Rethinking the role of tube feeding in patients with advanced dementia. NEJM 342:206-9.
142. Gillick MR. 2004. Medicare coverage for technological innovations-time for new criteria? NEJM 350:2199-2203.
143. Gilsdorf JR. 2004. As drug marketing pays off, my mother pays up. Health Aff 23:208-12.
144. Goldman DP, GF Joyce, and JJ Escarce. 2004. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 291:2344-50.
145. Goldstein A. 2001. Better than a nursing home? www.time.com, vol 158; no 6 (8/13/01).
146. Goode E. 2003. Leading drugs for psychosis come under new scrutiny. New York Times (5/20/03) A1.
147. Goodwin J. 1999. Geriatrics and the limits of modern medicine. NEJM 340:1283-85.
148. Gornick V. 1999. Alive in New York until the last minute. Nation (5/24/99) 22-23.
149. Gould E., AJ Reeves, MS Graziano, et al. 1999. Neurogenesis in the neocortex of adult primates. Science 86:548-52.
150. Goulding MR. 2004. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 164:305-12.
151. Government Accounting Office [GAO]. 2002. Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations. www.gao.gov/new .items/d03177.pdf.
152. Grady D, D Herrington, V Bittner, et al. 2002. Cardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA 288:40-57.
153. Graham D, D Campen, R Hui, et al. 2005. Risk of acute myocardial infarction and sudden cardiac death in patients treated with Cox-2 selective and nonselective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365:475-81.
154. Greenhouse L. 2005. Justices accept case weighing assisted suicide. New York Times (2/23/05) A1.
155. Gregg EW, JA Cauley, K Stone, et al. 2003. Relationship of changes in physical activity and mortality among older women. JAMA 289:2379-86.
156. Groopman J. 2002. Dying words. New Yorker (10/28/02) 62-70.
157. Gross DJ, SW Schondolmeyer, and SO Retzman. 2004. Trends in manufacturer prices of brand name prescription drugs used by older Americans, 2000 through 2003. AARP Public Policy Institute publication ID: 2004-06.
158. Gross J. 2004. Older women team up to face future together. New York Times (2/27/04) A1.
159. Grumbach K, and T Bodenheimer. 2004. Can health care teams improve primary care practice? JAMA 291:1246-51.
160. Grundman M, RC Petersen, SH Ferris, et al. 2004. Mild cognitive impairment can be distinguished from Alzheimer Disease and normal aging for clinical trials. Arch Neurol 61:59-66.
161. Gudrais E. 2001. The brain at midlife. Harvard Magazine (May-June 2000) 9-10.
162. Guralnik JM. 1996. Assessing the impact of comorbidity in the older population. Annals Epidemiol 6:376-80.
163. Guralnik JM, LP Fried, and ME Salive. 1996. Disability as a public health outcome in the aging population. Annu Rev Public Health 17:25-46.
164. Gurwitz JH, TS Field, LR Harrold, et al. 2003. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289:1107-16.
165. Gustafson D, E Rothenberg, K Blennow, et al. 2003. An 18-year follow-up of overweight and risk of Alzheimer Disease. Arch Intern Med 163:1524-28.
166. Hadler N. 2003. A ripe old age. Arch Intern Med 163:1261-62.
167. Hampton T. 2004. Similar drug names a risky prescription. JAMA 291:1948-49.
168. Hardy SE, and TM Gill. 2004. Recovery from disability among communitydwelling older persons. JAMA 291:1596-1602.
169. Harrington C, R Newcomer, and P Fox. 2001. Long-term care for older Californians. California Policy Research Center Brief: Strategic Planning on Aging no 9 (May 2001).
170. Harris G. 2003a. U.S. moves to halt import of drugs from Canada. New York Times (9/10/03) C2.
171. Harris G. 2003b. Drug makers resist state efforts to cut Medicaid expenses. New York Times (12/18/03) A1.
172. Harris G. 2004a. 2 cancer drugs, no comparative data. New York Times (2/26/04) C1.
173. Harris G. 2004b. As doctor writes prescription, drug company writes a check. New York Times (6/27/04) A1.
174. Harris G. 2004c. Guilty plea seen for drug maker. New York Times (7/16/04) A1.
175. Harris G. 2004d. Proposal would slash what Medicare pays for cancer drugs. New York Times (7/27/04) C1.
176. Harris G. 2004e. At FDA, strong drug ties and less monitoring. New York Times (12/6/04) A1.
177. Hays J, Ockene JK, RL Brunner, et al. 2003. Effects of estrogen plus progestin on health-related quality of life. NEJM 348:1839-54.
178. Helft PR, M Siegler, and J Lantos. 2000. The rise and fall of the futility movement. NEJM 343:293-96.
179. Hilts PJ. 1999. Life at 100 is surprisingly healthy. New York Times (6/1/99) A1.
180. Himmelstein DU, E Warren, D Thorne, et al. 2005. Illness and injury as contributors to bankruptcy. Health Aff www.healthaffairs.org, (accessed 2/2/05).
181. Himmelstein DU, S Woolhandler, I Hellander, et al. 1999. Quality of care in investor-owned vs. not-for-profit HMOs. JAMA 282:159-63.
182. Hodis HN, WJ Mack, SP Azen, et al. 2003. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. NEJM 349:535-45.
183. Holman H. 2004. Chronic disease-the need for a new clinical education. JAMA 292:1057-59.
184. Horton R. 2004a. The dawn of McScience. New York Review of Books (3/11/04) 7-9.
185. Horton R. 2004b. Vioxx, the implosion of Merck, and aftershocks at the FDA. Lancet 364:1995-96.
186. Hulley S, C Furberg, E Barrett-Connor, et al. 2002. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA 288:58-66.
187. Hulley SB, and D Grady. 2004. The WHI estrogen-alone trial-do things look any better? JAMA 291:1769-71.
188. Humphry D. 1996. Final exit: the practicalities of self-deliverance and assisted suicide for the dying. New York: Dell.
189. Hurley AC, and L Volicer. 2002. Alzheimer Disease. JAMA 288:2324-31.
190. Huskamp H, PA Deverka, AM Epstein, et al. 2003. The effect of incentivebased formularies on prescription-drug utilization and spending. NEJM 349:2224-32. Iglehart JK. 2004. The new Medicare prescription drug benefit-a pure power play. NEJM 350:826-33.
191. Inouye SK, ST Bogardus, PA Charpentier, et al. 1999. A multicomponent intervention to prevent delirium in hospitalized older patients. NEJM 340:669-76.
192. Institute for the Study of Aging. 2001. Achieving and maintaining cognitive vitality with aging: a workshop report. New York: International Longevity Center www.ilcusa.irg/publications; www.aging-institute.org.
193. Institute of Medicine. 2004. Insuring America's health: principles and recommendations. www.iom.org.edu/uninsured.
194. International Committee of Medical Journal Editors. 2004. Clinical trial registration. JAMA 292:1363-64.
195. Isaacs SL, and SA Schroeder. 2004. Class-the ignored determinant of the nation's health. NEJM 351:1137-42.
196. Jacobs S. 2003. Death by voluntary dehydration-What the caregivers say. NEJM 349:325-26.
197. Jagust W. 2001. Untangling vascular dementia. Lancet 358:2097-98.
198. Janofsky M. 2004. Costs and savings in Medicare change on wheelchairs. New York Times (1/30/04) A10.
199. Jasny BR, and L Roberts, eds. Are we there yet? Science 302:587-608.
200. Jenkins JA, CW Kendall, A Marchie, et al. 2003. Effects of dietary portfolio of cholesterol-lowering foods vs. lovastatin on serum lipids and C-reactive protein. JAMA 290:502-12.
201. Jette, AM, M Lachman, MM Giorgetti, et al. 1999. Exercise-it's never too late. Am J Public Health 89:66-72.
202. Jones RW. 2001. Inflammation and Alzheimer's disease. Lancet 358:436-37.
203. Juni P, L Nartey, S Reichenbach, et al. 2004. Risk of cardiovascular event and rofecoxib: cumulative meta-analysis. Lancet 364:2021-2029.
204. Juurlink DN, M Mamdani, A Kopp, et al. 2003. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289:1652-58. Kaiser/Hewitt 2004. Survey on retiree health benefits. www.kff.org/medicare (accessed 12/14/04).
205. Kantrowitz B. 2000. The new middle age: a boomer's guide to health, wealth and happiness. Newsweek (4/3/00) 57.
206. Kassirer J. 1998. Doctor discontent. NEJM 339:1543-54.
207. Katz SJ, K Mohammed, and KM Langa. 2000. Gender disparities in the receipt of home care for elderly people in the United States. JAMA 284:3022-27.
208. Kaufman SR. 1986. The ageless self: sources of meaning in late life. Madison: University of Wisconsin Press.
209. Kawas CH. 2003. Early Alzheimer's Disease. NEJM 349:1056-63.
210. Kennedy T. 2004. Dramatic improvement or death spiral. NEJM 350:747-49.
211. Kerr EA, EA McGlynn, J Adams, et al. 2004. Profiling the quality of care in twelve communities: results from the CQI study. Health Aff 23:247-56.
212. Kirkwood TB. 2000. Evolution of aging: how genetic factors affect the end of life. Generations (Spring 2000) 12-18.
213. Kleinfeld NR. 2003. For elderly, fear of falls is a risk in itself. New York Times (3/5/03) A1.
214. Knoops KT, LC deGroot, D Kromhout, et al. 2004. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292:1433-39.
215. Koepsell T, L McCloskey, M Wolf, et al. 2002. Crosswalk markings and the risk of pedestrian-motor vehicle collisions in older pedestrians. JAMA 288:2136-43.
216. Kolata G. 2003. Bone diagnosis gives new data but no answers. New York Times (9/28/03) A1.
217. Kolata G. 2004. With costs rising, treating back pain often seems futile. New York Times (2/9/04) A1.
218. Kolata G, and EL Andrews. 2001. Anticholesterol drug pulled after link with 31 deaths. New York Times (8/9/01) C1.
219. Kovacs FM, V Abraira, A Pena, et al. 2003. Effect of firmness of mattress on chronic non-specific back pain: a randomized, double-blind controlled, multicentre trial. Lancet 362:1599-1604.
220. Kuttner R. 1998. Must good HMOs go bad? NEJM 338:1558-63, 1635-39.
221. Lachs MS, and K Pillemer. 2004. Elder abuse. Lancet 364:1263-72.
222. Lamberg L. 2002. "Palliative care" means "active care." JAMA 288:943-44.
223. Landefeld CS, CM Callahan, and N Woolard, eds. 2003. Improving geriatrics training: training internists in the care of older adults (suppl). Ann Intern Med 139:607-34.
224. Landes AM, SD Sperry, and ME Strauss. 2001. Apathy in Alzheimer's Disease. J Am Geriatr Soc 49:1700-1707.
225. Landon BE, AM Zaslavsky, and SL Bernard. 2004. Comparison of performance of traditional Medicare vs Medicare managed care. JAMA 291:1744-52.
226. Langa KM, NL Foster, and EB Larson. 2004. Mixed dementia. JAMA 292:2901-08.
227. Lantz PM, JS House, JM Lepkowski, et al. 1998. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA 279:1703-08.
228. Larsen DG, and DR Tobin. 2000. End of life conversations. JAMA 284:1573-78.
229. Lasser KE, PD Allen, S Woolhandler, et al. 2002. Timing of new black warnings and withdrawals for prescription medications. JAMA 287:2215-20.
230. Leiberman T. 1998. Hunger in America. Nation (3/30/98) 11-16.
231. Levine SA, J Boal, and PA Boling. 2003. Home care. JAMA 290:1203-07.
232. Levit K, C Smith, C Cowan, et al. 2003. Trends in health care spending, 2001. Health Aff 22:154-64.
233. Levit K, C Smith, C Cowan, et al. 2004. Health spending rebound continues in 2002. Health Aff 23:147-56.
234. Lewontin R. 2001. After the genome, what then? New York Review of Books (7/9/01) 36.
235. Li F, KJ Fisher, P Harmer, et al. 2002. Delineating the impact of tai chi training on physical function among the elderly. Am J Prev Med 23:92-97.
236. Lin HB, W Katon, M VonDorff, et al. 2003. Effect of improving depression care on pain and functional outcomes in older adults with arthritis. JAMA 290:2428-34.
237. Liptak A. 2004. Ruling upholds law authorizing assisted suicide. New York Times (5/27/04) A1.
238. Lu T, Y Pan, S-Y Kao, et al. 2004. Gene regulation and DNA damage in the ageing human brain. Nature 429:883-91.
239. Lunney JR, J Lynn, DJ Foley, et al. 2003. Patterns of functional decline at the end of life. JAMA 289:2387-92.
240. Lyness JM. 2004. Treatment of depressive conditions in later life. JAMA 291:1626-27.
241. Lynn J. 2001. Serving patients who may die soon. JAMA 285:925-32.
242. Lynn J. 2004. Sick to death and not going to take it anymore! Berkeley and Los Angeles: University of California Press.
243. Lynn J, JM Teno, RS Phillips, et al. 1997. Perceptions by family members of the dying experience of older and seriously ill patients. Ann Intern Med 126:97-106.
244. Madrick J. 2003. Health for sale. New York Review of Books (12/18/03) 71-74.
245. Manion FA. 1998. Should we accept mediocrity? NEJM 338:1067-69.
246. Manion FA. 1999. Whither continuity of care? NEJM 340:1362-63.
247. Manson JE, J Hsia, KC Johnson, et al. 2003. Estrogen plus progestin and the risk of coronary heart disease. NEJM 349:523-34.
248. Manton KG, and X Gu. 2001. Changes in the prevention of chronic disability in the United States black and non-black population above age 65 from 1982-99. Proc Natl Acad Sci 98:6354-59.
249. Margolis S, and PV Rabin. 2002. Memory. Baltimore MD: Johns Hopkins Medical Institutes.
250. Mariner WK. 2004. The Supreme Court's limitation of managed-care liability. NEJM 351:1347-51.
251. Mattimore TJ, NS Wenger, NA Desbiens, et al. 1997. Surrogate and physician understanding of patients' preferences for living permanently in a nursing home. J Am Geriatr Soc 45:818-24.
252. Maxwell RJ, and DJ Webb. 2005. Cox-2 selective inhibitors-important lessons learned. Lancet 365:449-51.
253. McClain CS, B Rosenfeld, and W Breitbart. 2003. Effect of spiritual wellbeing on end-of-life despair in terminally-ill cancer patients. Lancet 361: 1603-07.
254. McCormick D, DU Himmelstein, S Woolhandler, et al. 2004. Single-payer national health insurance: physicians' views. Arch Intern Med 164:300-304.
255. McGlynn EA, SM Asch, J Adams, et al. 2003. The quality of health care delivered to adults in the U.S. NEJM 348:2635-45.
256. McWilliams JM, AM Zaslavsky, E Meara, et al. 2003. Impact of Medicare coverage on basic clinical services for previously uninsured adults. JAMA 290:757-64.
257. Meier B. 2004a. Group is said to seek full drug-trial disclosure. New York Times (6/15/04) A1.
258. Meier B. 2004b. A.M.A. urges disclosure on drug trials. New York Times (6/17/04) C1.
259. Meier DE, C Emmons, A Litke, et al. 2003. Characteristics of patients requesting and receiving physician-assisted death. Arch Intern Med 163:1537-42.
260. Meier DE, and RS Morrison. 2002. Autonomy reconsidered. NEJM 346:1087-88.
261. Mello MM, DM Studdert, and TA Brennan. 2004. The pharmaceutical industry versus Medicaid-limits on state initiatives to control prescription-drug costs. NEJM 350:608-12.
262. Mesulam MM. 2003. Primary progressive aphasia-a language-based dementia. NEJM 349:1535-42.
263. Miles S, and K Parker. 1997. Men, women, and health insurance. NEJM 336:218-20.
264. Mitchell JL, KJ Cruickshanks, BE Klein, et al. 2003. Postmenopausal hormone therapy and its association with cognitive impairment. Arch Intern Med 163:2485-90.
265. Mitchell SL, DK Kiely, and MB Hamel. 2004. Dying with advanced dementia in the nursing home. Arch Intern Med 164:321-26.
266. Mitchell SL, DK Kiely, MB Hamel, et al. 2004. Estimating prognosis for nursing home residents with advanced dementia. JAMA 291:2734-40.
267. Mitchell SL, JM Teno, J Roy, et al. 2003. Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment. JAMA 290:73-80.
268. Mitka M. 2003. Survey suggesting that prescription drug ads help public met with skepticism. JAMA 289:827-28.
269. Mold JW, and LA Green. 2003. General internists and family physicians: partners in geriatric medicine? Ann Intern Med 139:594-95.
270. Morrison RS, and DE Meier. 2004. Palliative care. NEJM 350:2582-90.
271. Morrison RS, and AL Siu. 2000. Survival in end-stage dementia following acute illness. JAMA 283:47-52.
272. Moyers B. 2000. On our own terms. Public Broadcasting Corporation video #10473-76.
273. Myerhoff B. 1978. Number our days. New York: Simon & Schuster.
274. National study of adult day services, 2001-2002. 2002. www.rwjf.org/news/special/adultdayServicesStudy (accessed 9/4/03).
275. Naylor MD, D Brooten, R Campbell, et al. 1999. Comprehensive discharge planning and home follow-up of hospitalized elders. JAMA 281:613-20.
276. Needleman J, P Buerhaus, S Mattke, et al. 2002. Nursing staff levels and the quality of care in hospitals. NEJM 346:1715-22.
277. Newcomer R, and R Maynard. 2001. Residential care for older Californians. California Policy Research Center Brief: Strategic Planning on Aging no 10.
278. Newhouse JP. 2000. Switching health plans to obtain drug coverage. JAMA 283:2161-62.
279. Nuland S. 1993. How we die. New York: Random House.
280. Nuland S. 2000. Physician-assisted suicide and euthanasia in practice. NEJM 342:583-85.
281. Olshansky SJ, and BA Carnes. 2001. The quest for immortality. New York: WW Norton.
282. Olshansky SJ, MA Rudberg, BA Carnes, et al. 1991. Trading off longer life for worsening health. J Aging Health 3:194-216.
283. Onwuteaka-Philipsen BD, A van der Heide, D Koper, et al. 2003. Euthanasia and other end-of life decisions in the Netherlands in 1990, 1995, and 2001. Lancet 362:395-99.
284. Orentlicher D. 1997. The Supreme Court and physician-assisted suicide. NEJM 337:1236-39.
285. Orentlicher D, and A Caplan. 2000. The Pain Relief Promotion Act of 1999: a serious threat to palliative care. JAMA 283:255-58.
286. Outpatient Service Trialists. 2004. Rehabilitation therapy services for stroke patients living at home: systematic review of randomised trials. Lancet 363:352-56.
287. Pantilat SZ, A Alpers, and RM Wachter. 1999. A new doctor in the house. JAMA 282:171-74.
288. Pantilat SZ, and AE Steimle. 2004. Palliative care for patients with heart failure. JAMA 291:2476-82.
289. Pear R. 1998a. Home-care denial in Medicare is ruled improper. New York Times (2/15/98) A1.
290. Pear R. 1998b. Hospitals told not to delay emergency room treatment. New York Times (12/1/98) A1.
291. Pear R. 1999. Clinton lays out plan to overhaul Medicare system. New York Times (6/30/99) A1.
292. Pear R. 2000a. Medicare spending for care at home plunges by 45%. New York Times (4/21/00) A1.
293. Pear R. 2000b. Justice Souter takes on a health care taboo. New York Times (6/18/00) A1.
294. Pear R. 2000c. U.S. recommending strict new rules at nursing homes. New York Times (7/23/00) A1.
295. Pear R. 2000d. Rise in health care costs rests largely on drug prices. New York Times (11/14/00) A1.
296. Pear R. 2001. Spending on prescription drugs increases by almost 19%. New York Times (5/8/01) A1.
297. Pear R. 2002a. Propelled by drug and hospital costs, health spending surged in 2000. New York Times (1/8/02) A16.
298. Pear R. 2002b. Nine in ten nursing homes lack adequate staff, study finds. New York Times (2/18/02) A1.
299. Pear R. 2002c. Medicare is now covering treatment for Alzheimer's. New York Times (3/31/02) A1.
300. Pear R. 2002d. U.S. begins issuing consumer data on nursing homes. New York Times (4/25/02) A1.
301. Pear R. 2002e. Investigators find repeated deception in ads for drugs. New York Times (12/4/02) A1.
302. Pear R. 2003a. Bush pushes plan to curb appeals in Medicare cases. New York Times (3/16/03) A1.
303. Pear R. 2003b. U.S. limiting costs of drugs for Medicare. New York Times (4/21/03) A1.
304. Pear R. 2003c. Congress weighs drug comparisons. New York Times (8/24/03) A1.
305. Pear R. 2003d. Emergency rooms get eased rules on patient care. New York Times (9/3/03) A1.
306. Pear R. 2003e. Rising costs prompt states to reduce Medicaid further. New York Times (9/23/03) A16.
307. Pear R. 2003f. Proposed rule would ease stance on feeding at nursing homes. New York Times (9/25/03) A19.
308. Pear R. 2003g. House and senate weigh co-payment for care at home. New York Times (10/14/03) A14.
309. Pear R. 2003h. New Medicare plan for drug benefits prohibits insurance. New York Times (12/7/03) A1.
310. Pear R. 2004a. Health spending at a record level. New York Times (1/9/04) A1.
311. Pear R. 2004b. Bush's aides see higher price tag for drug benefit. New York Times (1/30/04) A1.
312. Pear R. 2004c. Taking spin out of report that made bad into good. New York Times (2/22/04) A16.
313. Pear R. 2004d. Investigators say drug makers repeatedly overcharge. New York Times (6/30/04) A17.
314. Pear R. 2004e. Inquiry confirms top Medicare official threatened actuary over cost of drug benefits. New York Times (7/7/04) A17.
315. Pear R. 2004f. Drug law is seen causing big drop in retiree plans. New York Times (7/14/04) A1.
316. Pear R. 2004g. New Medicare drug plan is raising difficult issues for nursing home patients. New York Times (12/5/04) A24.
317. Pear R. 2005. Estimate revives fight on Medicare costs. New York Times (2/20/05) A16.
318. Pear R, and M Freudenheim. 2004. Drug discounts beginning today, but signups lag. New York Times (6/1/04) A1.
319. Pear R, and RA Oppel, Jr. 2002. Election gives industry new influence. New York Times (11/21/02) A1.
320. Pennix BJ, S Leveille, L Ferrucci, et al. 1999. Exploring the effect of depression on physical disability. Am J Public Health 89:1346-52.
321. Petersen M. 2001. Doubts are raised on the safety of two popular arthritis drugs. New York Times (5/22/01) C1.
322. Petersen M. 2002. Madison avenue plays growing role in the business of drug research. New York Times (11/22/02) A1.
323. Petersen M. 2003. Who's minding the drugstore? New York Times (6/29/03) Section 3:1.
324. Petersen M, and A Berenson. 2003. Papers indicate that Bayer knew of dangers of its cholesterol drug. New York Times (2/22/03) A1.
325. Philips D, N Christenfeld, and LM Glynn. 1998. Increase in United States prescription error deaths between 1983 and 1993. Lancet 351:634-44.
326. Phillips CO, SM Wright, DE Kern, et al. 2004. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure. JAMA 291:1358-67.
327. Physicians' Working Group for Single-Payer National Health Insurance. 2003. Proposal of the physicians' working group for single-payer national health insurance. JAMA 290:798-805.
328. Porter E. 2004. Cost of benefits cited as factor in slump in jobs. New York Times (8/19/04) A1.
329. Prendergast TJ, and KA Puntillo. 2002. Withdrawal of life support. JAMA 288:2732-40.
330. Press D. 2004. Parkinson's dementia-a first step? NEJM 351:2547-49.
331. Prigerson HG. 2003. Costs to society of family caregiving for patients with endstage Alzheimer's Disease. NEJM 349:1891-92.
332. Psaty BM, CD Furberg, WA Ray, et al. 2004. Potential for conflict of interest in the evaluation of suspected adverse drug reaction. JAMA 292:2622-31.
333. Public Citizen Health Research Group. 2003. do not use! Health Letter 19:3-5.
334. Public Citizen Health Research Group. 2004. Medizine: drug ads masquerading as news. Health Letter 20:12.
335. Puca A, MJ Daly, SJ Brewster, et al. 2001. A genetic scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc Natl Acad Sci 98:1505-8.
336. Quill TE. 1991. Death and dignity: a case of individualized decision-making. NEJM 324:692-94.
337. Quill TE. 2004. Dying and decision making-evolution of end-of-life options. NEJM 350:2029-32.
338. Rabow MW, JM Hauser, and J Adams. 2004. Supporting family caregivers at the end of life. JAMA 291:483-91.
339. Rafkin HS, and T Rainey. 1997. Experience in the critical care setting. In Zucker MB, and HD Zucker, eds., Medical futility and the evaluation of lifesustaining interventions. Cambridge: Cambridge University Press.
340. Ramachandrian VS. 2000. Memory and the brain: new lessons from old symptoms. In Schacter DL, and E Scarry, eds., Memory, brain, and belief. Cambridge MA: Harvard University Press.
341. Rao SV, KA Schulman, LH Curtis, et al. 2004. Socioeconomic status and outcome following acute myocardial infarction in elderly patients. Arch Intern Med 164:1128-33.
342. Rapp SR, MA Espeland, SA Shumaker, et al. 2003. Effect of estrogen plus progestin on global cognitive function in postmenopausal women. JAMA 289:2663-72.
343. Raskind M, ER Peskind, L Truyen, et al. 2004. The cognitive benefits of galantamine are sustained for at least 36 months. Arch Neurol 61:252-56.
344. Rawls J. 2001. Justice as fairness. Cambridge MA: Harvard University Press.
345. Rector T. 2000. Exhaustion of drug benefits and disenrollment of Medicare beneficiaries from managed care organizations. JAMA 283:2163-67.
346. Regalado A. 2003. To sell pricey drug, Lilly fuels a debate over rationing. Wall Street Journal (9/18/03) A1.
347. Reinhardt UE. 1997. Wanted: a clearly articulated social ethic for American health care. JAMA 278:1446-47.
348. Reinhardt UE. 2004. An information infrastructure for the pharmaceutical market. Health Aff 23:107-12.
349. Reisberg B, R Doody, A Stoffler, et al. 2003. Memantine in moderate-to-severe Alzheimer's Disease. NEJM 348:1333-41.
350. Rennie D. 2004. Trial registration. JAMA 292:1359-62.
351. Retchin SM, RS Brown, SC Yeh, et al. 1997. Outcomes of stroke patients in Medicare fee-for-service and managed care. JAMA 278:119-24.
352. Retirees pioneer a health program just for them. 2000. San Francisco Chronicle (8/7/00) A1.
353. Rhymes JA, LB McCullough, RJ Luchi, et al. 2000. Withdrawing very lowburden interventions in chronically ill patients. JAMA 283:1061-67.
354. Riley T, and E Kilbreth. 2004. Health coverage in the states-Maine's plan for universal access. NEJM 350:330-32.
355. Rimer S. 1998. Seattle's elderly find a home for living, not dying. New York Times (11/22/98) A1.
356. Rimer S. 1999. Caring for elderly kin can be costly, study finds. New York Times (11/27/99) A1.
357. Rimm EB, and MJ Stampfer. 2004. Diet, lifestyle, and longevity-the next steps? JAMA 292:1490-92.
358. Ritchie K, and S Lovestone. 2002. The dementias. Lancet 360:1759-66.
359. Robinson JC. 2004. Reinvention of health insurance in the consumer era. JAMA 291:1880-86.
360. Rochon PA, and JH Gurwitz. 1999. Prescribing for seniors: neither too much nor too little. JAMA 282:113-15.
361. Rocker GM, and JR Curtis. 2003. Caring for the dying in the intensive care unit. JAMA 290:820-22.
362. Rowe JW. 1999. Geriatrics, prevention, and the remodeling of Medicare. NEJM 340:720-21.
363. Rowe JW, and RL Kahn. 1997. Successful aging. Gerontologist 37:433-40.
364. Rowe JW, and RL Kahn. 1999. Successful aging. New York: Dell.
365. Rubenstein LZ. 1996. Update on preventive medicine for older people. Generations (Winter 1996-97) 47-53.
366. Safran DG, P Newman, C Shoen, et al. 2002. Prescription drug coverage and seniors: how well are states closing the gaps? Health Aff www.healthaffairs.org:W253-W268.
367. Satariano WA, GN DeLovenze, D Reed, et al. 1996. Imbalance in an older population: an epidemiological analysis. J Aging Health 8:334-58.
368. Scherer FM. 2004. The pharmaceutical industry-prices and progress. NEJM 351:927-32.
369. Schevitz T. 1999. For many, retiring early means ailments win. San Francisco Chronicle (9/7/99) A17.
370. Schneider LS. 2004a. AD2000: Donepezil in Alzheimer's disease. Lancet 363:2100-2101.
371. Schneider LS. 2004b. Estrogen and dementia. JAMA 291:3005-07.
372. Schneiderman LJ, T Gilmer, HD Teetzel, et al. 2003. Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting. JAMA 290:1166-72.
373. Schoeni RF, VA Freedman, and RB Wallace. 2001. Persistent, consistent, widespread, and robust? Another look at recent trends in old-age disability. J Gerontol: Soc Sci 56 B:S206-18.
374. Schulz R, and SR Beach. 1999. Caregiving as a risk factor for mortality. JAMA 282:2215-19.
375. Schulz R, SH Belle, SJ Czaja, et al. 2004. Long-term care placement of dementia patients and caregiver health and well-being. JAMA 292:961-67.
376. Schulz R, AB Mendelsohn, WE Haley, et al. 2003. End-of-life care and the effects of bereavement on family caregivers of persons with dementia. NEJM 349:1936-42.
377. Schwartz WB. 1998. Life without disease. Berkeley and Los Angeles: University of California Press.
378. Shumaker SA, C Legault, L Kuller, et al. 2004. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA 291:2947-58.
379. Shumaker SA, C Legault, SR Rapp, et al. 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA 289:2651-62.
380. Singer PA, DK Martin, and M Kelner. 1999. Quality end-of-life care: patients' perspective. JAMA 281:163-68.
381. Sink KM, KF Holden, and K Yaffe. 2005. Pharmacological treatment of neuropsychiatric symptoms of dementia. JAMA 293:596-608.
382. Smith NL, SR Heckbert, RN Lemaitre, et al. 2004. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 292:1581-87.
383. Snowden D. 2001. Aging with grace. New York: Bantam.
384. Solomon PR, F Adams, A Silver, et al. 2002. Ginkgo biloba for memory enhancement: a randomized controlled trial. JAMA 287:835-40.
385. Soumerai SB, and D Ross-Degnan. 1999. Inadequate prescription-drug coverage for Medicare enrollees-A call to action. NEJM 340:722-27.
386. Spector M. 2001. Rethinking the brain. New Yorker (7/23/01) 42-53.
387. Sprung CL, SL Cohen, P Sjokvist, et al. 2003. End-of-life practices in European intensive care units. JAMA 290:790-97.
388. St. John K. 2000. Critical condition. San Francisco Chronicle (11/20/00) A1.
389. Steinbrook R. 2002. Physician-assisted suicide in Oregon-an uncertain future. NEJM 346:460-64.
390. Steinbrook R. 2004a. Disparities in health care-from politics to policy. NEJM 350:1486-88.
391. Steinbrook R. 2004b. The cost of admission-tiered copayments for hospital use. NEJM 350:2539-42.
392. Steinbrook R. 2004c. Public registration of clinical trials. NEJM 351:315-17.
393. Steinhauer J. 2000. Emergency room, to many, remains the doctor's office. New York Times (10/25/00) A1.
394. Steinbrook R. 2001. As assisted living centers grow, calls for standards and oversight. New York Times (2/12/01) A1.
395. Stern PS, and LL Carstensen, eds. 2002. The aging mind: opportunities in cognitive research. Washington DC: National Academy Press.
396. Stolberg SG. 1999. The boom in medications brings rise in fatal risks. New York Times (6/3/99) A1.
397. Stolberg SG. 2000a. Drug plan sounds great, but who gets to set prices? New York Times (7/9/00) A1.
398. Stolberg SG. 2000b. FDA warns of overuse of two new drugs against flu. New York Times (1/13/00) A1.
399. Stolberg SG, and J Gerth. 2000a. How companies stall generics and keep themselves healthy. New York Times (7/23/00) A1.
400. Stolberg SG, and J Gerth. 2000b. High-tech stealth being used to sway doctor prescriptions. New York Times (11/16/00) A1.
401. Strom BL. 2004. Potential for conflict of interest in the evaluation of suspected adverse drug reaction: a counterpoint. JAMA 292:2643-45.
402. Strunk B, and PB Ginsburg. 2003. Tracking health care costs: trends stabilize but remain high in 2002. Health Aff 22:12-23.
403. Stuck AE, JC Beck, and M Egger. 2004. Preventing disability in elderly people. Lancet 364:1641-42.
404. Sullivan AD, K Hedberg, and DW Fleming. 2000. Legalized physician-assisted suicide in Oregon-the 2nd year. NEJM 342:598-64.
405. SUPPORT. 1995. A controlled trial to improve care for seriously ill hospitalized patients. JAMA 274:1591-98.
406. Survey finds boomer women not preparing for golden years. 2000. Berkeley Voice (7/21/00) 1.
407. Tamblyn R, R Laprise, JA Hanley, et al. 2001. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 285:421-29.
408. Tariot PN, MR Farlow, GT Grossberg, et al. 2004. Memantine treatment in patients with moderate to severe Alzheimer Disease already receiving donepezil. JAMA 291:317-24.
409. Taylor B. 2004. Giveaway drugs: good intentions, bad design. Health Aff 23:213-17.
410. Teno JM, BR Clarridge, V Casey, et al. 2004. Family perspectives on end-of-life care at the last place of care. JAMA 291:88-93.
411. Teri L, LE Gibbons, SM McCurry, et al. 2003. Exercise plus behavioral management in patients with Alzheimer Disease. JAMA 290:2015-22.
412. Thomas CP. 2003. Incentive-based formularies. NEJM 349:2186-88.
413. Thomas DC, RM Leipzig, LG Smith, et al. 2003. Improving geriatrics training in internal medicine residency programs. Ann Intern Med 139:628-34.
414. Tinetti ME. 2003. Preventing falls in elderly persons. NEJM 348:42-47.
415. Tinetti ME, DI Baker, G McAvay, et al. 1994. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. NEJM 331:821-27.
416. Tinetti ME, ND Baker, and WT Gallo. 2002. Evaluation of restorative care vs. usual care for older adults receiving an acute episode of home care. JAMA 287:2098-2105.
417. Tinetti, ME, CS Williams, and TM Gill. 2000. Health, functional, and psychological outcomes among older persons with chronic dizziness. J Amer Geriatric Soc 48:417-21.
418. Toner R. 1999. Drawing up plans to pay for pills for the elderly. New York Times (5/10/99) A1.
419. Topol EJ. 2004. Failing the public health-rofecoxib, Merck, and the FDA. NEJM 351:1707-09.
420. Topol EJ. 2005. Arthritis medicines and cardiovascular event-"house of coxibs." JAMA 293:366-68.
421. Topol EJ, and GW Falk. 2004. A coxib a day won't keep the doctor away. Lancet 364:639-40.
422. Trinh N, J Hoblyn, S Mohanty, et al. 2003. Efficacy of cholinesterase inhibitors in the treatment of neuropsychological symptoms and functional impairment in Alzheimer's Disease. JAMA 289:210-16.
423. Tseng CW, RH Brook, E Keeler. 2004. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA 292:952-60.
424. Tunis SR. 2004. Why Medicare has not established criteria for coverage decisions. NEJM 350:2196-98.
425. Union of Concerned Scientists. 2004. Scientific integrity in policymaking-executive summary. www2.ucsusa.org.
426. Unutzer J, W Katon, CM Callahan, et al. 2002. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 288:2836-45.
427. van der Heide A, L Dellens, K Faisst, et al. 2003. End-of-life decision-making in six European countries: descriptive study. Lancet 361:345-50.
428. van der Heide A, J van Delden, and G van der Wal. 2004. Doctor-assisted dying: what difference does legalisation make? Lancet 364:24-25.
429. Verghese J, RB Lipton, MJ Katz, et al. 2003. Leisure activities and the risk of dementia in the elderly. NEJM 348:2508-16.
430. Vermeer SE, ND Prins, T den Heijer, et al. 2003. Silent brain infarcts and the risk of dementia and cognitive decline. NEJM 348:1215-22.
431. Voelker R. 2003. Northern Rxposure. JAMA 290:2921.
432. Volz J. 2000. Successful aging: the second fifty. Monitor on Psychology 31:24-35.
433. Von Guten CF, FD Ferris, and LL Emanuel. 2000. Ensuring competency in endof-life care. JAMA 284:3051-57.
434. Wald ML. 2000. Accidental deaths on rise as the population ages fast. New York Times (4/26/00) A18.
435. Walter LC, and KE Covinsky. 2001. Cancer screening in elderly patients. JAMA 285:2750-56.
436. Wang C, JP Collet, and J Lau. 2004. The effect of tai chi on health outcomes in patients with chronic conditions. Arch Intern Med 164:493-501.
437. Wang H-X, A Wahlin, H Basun, et al. 2001. Vitamin B12 and folate in relation to development of Alzheimer's Disease. Neurology 56:1188-94.
438. Ware J, MS Bayliss, WH Rogers, et al. 1996. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and FFS systems. JAMA 276:1039-47.
439. Wassertheil-Smoller S, SL Hendrix, M Limacher, et al. 2003. Effect of estrogen plus progestin on stroke in postmenopausal women. JAMA 289:2673-84.
440. Wazana A. 2000. Physicians and the pharmaceutical industry. JAMA 283:373-80.
441. Weisbrot M. 2000. Rx for Medicare. San Francisco Chronicle (2/13/00) A1.
442. Weissman DE. 2004. Decision making at a time of crisis near the end of life. JAMA 292:1738-43.
443. Wenger NS, DH Solomon, CP Roth, et al. 2003. The quality of medical care provided to vulnerable community-dwelling older patients. Ann Intern Med 139:740-47.
444. Wenve J, JH Kang, JE Manson, et al. 2004. Physical activity, including walking, and cognitive function in older women. JAMA 292:1454-61.
445. Whalley L. 2001. The aging brain. New York: Columbia University Press.
446. Wilcock GK. 2003. Dementia with Lewy Bodies. Lancet 362:1689-90.
447. Willcox SM, DU Himmelstein, and S Woolhandler. 1994. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 272:292-96.
448. Wilson D. 2001. Some losing it, bit by bit. Los Angeles Times (7/17/01) A1.
449. Wilson RS, CF Mendes de Leon, LL Barnes, et al. 2002. Participation in cognitively stimulating activities and risk of incident Alzheimer's Disease. JAMA 287:742-48.
450. Winzelberg G. 2003. The quest for nursing home quality. Arch Intern Med 163:2552-56.
451. Wolf SL, HX Barnhart, NG Kutner, et al. 1996. Reducing frailty and falls in older persons: an investigation of t'ai chi and computerized balance training. J Am Geriatr Soc 44:489-97.
452. Wolfson C, DB Wolfson, M Asgharian, et al. 2001. A reevaluation of the duration of survival after onset of dementia. NEJM 344:111-16.
453. Women's Health Initiative [WHI] Steering Committee. 2004. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291:1701-12.
454. Woolhandler S, T Campbell, and DU Himmelstein. 2003. Costs of health care administration in the United States and Canada. NEJM 349:768-75.
455. Wysocki B. 2003. At one hospital, a stark solution for allocating care. Wall Street Journal (9/23/03) A1.
456. Yaffe K. 2003. Hormone therapy and the brain. JAMA 289:2717-19.
457. Yaffe K, P Fox, R Newcomer, et al. 2002. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 287:2090-97.
458. Zahn C, J Sangl, AS Bierman, et al. 2001. Potentially inappropriate medication use in the community-dwelling elderly. JAMA 286:2823-29.
459. Zandi PP, JC Anthony, AS Khachaturian, et al. 2004. Reduced risk of Alzheimer Disease in users of antioxidant vitamin supplements. Arch Neurol 61:82-88.